Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications

被引:175
作者
Picciotto, MR [1 ]
Caldarone, BJ [1 ]
Brunzell, DH [1 ]
Zachariou, V [1 ]
Stevens, TR [1 ]
King, SL [1 ]
机构
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA
关键词
knocking; mutation; nicotine; electrophysiology; behavior; equilibrium binding;
D O I
10.1016/S0163-7258(01)00161-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nicotinic acetylcholine receptors (nAChRs) in the muscle, autonomic ganglia, and brain are targets for pharmacologically administered nicotine. Several of the subunits that combine to form neuronal nicotinic receptors have been deleted by knockout or mutated by knockin in mice using homologous recombination. We will review the biochemical, pharmacological, anatomical, physiological, and behavioral phenotypes of mice with genetically altered neuronal nAChR subunits. Clinically relevant mutations in nAChR genes will also be discussed. In addition, some of the signal transduction pathways activated through nAChRs will be described in order to delineate the longer-term changes that might result from persistent activation or inactivation of nAChRs. Genetically manipulated mice have greatly increased our understanding of the subunit composition and physiological properties of nAChRs in vivo, In addition, these mice have provided a model system to determine the molecular basis for many of the pharmacological actions of nicotine on neurotransmitter release and behavior. Genetic manipulations in mice have also elucidated the role of nAChR subunits in various disease states, and suggest several avenues for drug development. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:89 / 108
页数:20
相关论文
共 176 条
[1]  
ADLER LE, 1982, BIOL PSYCHIAT, V17, P639
[2]   Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors [J].
Arias, HR .
NEUROCHEMISTRY INTERNATIONAL, 2000, 36 (07) :595-645
[3]   Chick optic lobe contains a developmentally regulated α2α5β2 nicotinic receptor subtype [J].
Balestra, B ;
Vailati, S ;
Moretti, M ;
Hanke, W ;
Clementi, F ;
Gotti, C .
MOLECULAR PHARMACOLOGY, 2000, 58 (02) :300-311
[4]  
Bansal A, 2000, J NEUROSCI, V20, P7672
[5]   CIGARETTE-SMOKING AND PARKINSONS-DISEASE [J].
BARON, JA .
NEUROLOGY, 1986, 36 (11) :1490-1496
[6]   MUTATIONS AT 2 DISTINCT SITES WITHIN THE CHANNEL DOMAIN M2 ALTER CALCIUM PERMEABILITY OF NEURONAL ALPHA-7 NICOTINIC RECEPTOR [J].
BERTRAND, D ;
GALZI, JL ;
DEVILLERSTHIERY, A ;
BERTRAND, S ;
CHANGEUX, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) :6971-6975
[7]   Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy [J].
Bertrand, S ;
Weiland, S ;
Berkovic, SF ;
Steinlein, OK ;
Bertrand, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (04) :751-760
[8]   Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat [J].
Bitner, RS ;
Nikkel, AL ;
Curzon, P ;
Donnelly-Roberts, DL ;
Puttfarcken, PS ;
Namovic, M ;
Jacobs, IC ;
Meyer, MD ;
Decker, MW .
BRAIN RESEARCH, 2000, 871 (01) :66-74
[9]  
BLUM A, 1996, LINGUA FRANCA, V6, P70
[10]  
BOOKER TK, 2000, SOC NEUR ABSTR, V26, P1405